THERAPEUTICS
Review: Antidepressants are of limited efficacy in juvenile depression
| The first 150 words of the full text of this article appear below. |
What is the efficacy of antidepressants in children and adolescents with depression?
Responder rate, defined as the proportion of the study sample reaching a study specified level of improvement in clinical ratings, typically a 50% or greater reduction in depressive symptoms.
Design: Systematic review with meta-analysis.
Data sources: MEDLINE, PsycINFO, EMBASE, Cochrane Library, PsiTri and ClinicalTrials.gov were searched from inception to May 2006 for randomised controlled trials (RCTs). Reference lists of identified studies were hand searched. Trial authors and experts in the field were consulted for unpublished information. Websites of pharmaceutical companies, the UK Committee on Safety of Medicines and the US FDA were also searched.
Study selection and analysis:
Two reviewers appraised the studies and selected RCTs comparing antidepressants with placebo in children and adolescents aged 20 years or less with major depression, dysthymia or depression not otherwise specified (DSM-III or later); depressive disorder (ICD-9/10); or depression diagnosed by
Cambridge and Peterborough NHS Foundation Trust and University of Cambridge, Cambridge, UK
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
